Benedetta Mariotti

Benedetta Mariotti

Auto-generated profile, based on publicly available information

Benedetta Mariotti

University Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2018 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
LCLaura Cudillo
Laura Cudillo
WNWilliam Arcese For The Rome Transplant Network
William Arcese For The Rome Transplant Network
RCRaffaella Cerretti
Raffaella Cerretti
APAlessandra Picardi
Alessandra Picardi
BMBenedetta Mariotti
Benedetta Mariotti
ALAlessandro Lanti
Alessandro Lanti

15 August 2017 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
CCCarlotta Cerva
Carlotta Cerva
GMG. Maffongelli
G. Maffongelli
VSValentina Svicher
Valentina Svicher
RSRomina Salpini
Romina Salpini
LCLuna Colagrossi
Luna Colagrossi
LSLoredana Sarmati
Loredana Sarmati
HBV reactivation is associated with high mortality rates in hematopoietic stem cell transplantation (HSCT) and prophylactic lamivudine (LMV) treatment is suggested to prevent this phenomenon. However, the duration of LMV treatment in HSCT patients is not fully defined and the time of immune recovery is considered the best parameter for a drug to be safely interrupted. In patients undergoing allogeneic HSCT, the time of immune recovery is not easy to define and may take years after transplantation and prolonged LMV treatments, which can lead to drug-resistant viral strains. An anti-HBc-positive hematological patient who was undergoing prolonged immunosuppression and who experienced HBV reactivation 3 months after the suspension of a prolonged LMV prophylaxis is described. HBV-DNA matching an atypical serological profile characterized by HbsAg negativity and anti-HBs positivity was detected in the patient. The genotypic analysis of the HBV strain identified T127P, F170FL and S204R mutations of HbsAg, which can hinder HBsAg recognition in a diagnostic assay. HBV reactivation in the HSCT host can be sustained by HBsAg viral variants with characteristics of altered immunogenicity that cannot be detected by usual laboratory tests. This clinical case description suggests the importance of screening for serum HBV-DNA levels in the diagnosis of HBV reactivation and monitoring HBV-DNA after prophylaxis suspension, particularly in HSCT subjects who have undergone prolonged periods of LMV treatment.

11 April 2019 in Case Reports in Hematology
Verified
Journal Article
Open access
PDF file
BMBenedetta Mariotti
Benedetta Mariotti
FMFederico Meconi
Federico Meconi
RPRaffaele Palmieri
Raffaele Palmieri
EBEleonora De Bellis
Eleonora De Bellis
SLSerena Lavorgna
Serena Lavorgna
LCLaura Cicconi
Laura Cicconi
We present a case report of a patient with acute myeloid leukemia (AML) characterized by the simultaneous presence of nucleophosmin 1 (NPM1) mutation and the breakpoint cluster region-Abelson (BCR-ABL) fusion oncogene. Our findings emphasize the importance of routinely including BCR-ABL in the diagnostic workup of AML in order to offer to the patients the most appropriate risk category and treatment options.

19 September 2019 in Case Reports in Infectious Diseases
Verified
Journal Article
Open access
PDF file
FMFederico Meconi
Federico Meconi
GCGiulia Ciangola
Giulia Ciangola
BMBenedetta Mariotti
Benedetta Mariotti
RCRaffaella Cerretti
Raffaella Cerretti
LCLaura Cudillo
Laura Cudillo
APAlessandra Picardi
Alessandra Picardi
Neurocysticercosis, an infection of the central nervous system with the larval stage of the cestode Taenia solium, is uncommon in developed countries. We report a case of allogeneic haematopoietic stem cell transplantation from a haploidentical donor complicated, in the long term, by T. solium infection of the central nervous system and successfully treated with empiric antiparasitic therapy with albendazole plus dexamethasone. Revised diagnostic criteria proposed by Del Brutto et al. were used for the definitive diagnosis of cerebellar neurocysticercosis.